Previous close | 41.88 |
Open | 36.50 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 35.67 - 39.65 |
52-week range | 13.89 - 43.04 |
Volume | |
Avg. volume | 681 |
Market cap | 2.245B |
Beta (5Y monthly) | 1.29 |
PE ratio (TTM) | 4.46 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Tandem Diabetes (TNDM) unveils survey results of the new Tandem Mobi insulin delivery system, underscoring its potential to significantly enhance the quality of life for people with diabetes
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Innovations and a robust diabetes market outlook raise investors' optimism for Tandem Diabetes (TNDM).